In excess of ten years have been invested into research and development and
now Plandaí Biotechnology, Inc. (PLPL), a producer of highly bioavailable
Phytofare™ plant extracts, is all set for commercialization.
The company is announcing three distinctive products into the $29-billion
U.S. nutritional supplements industry and $50-billion worldwide tea
industry. Vitamin Shoppe (VSI) estimates that 150 million people in the
U.S. take a dietary supplement every day. Plandaí’s products should
instantaneously charm this huge audience. This will give Plandaí
Biotechnology, Inc. (PLPL) a viable edge and should vault the company onto
The use of research materials created by the author is done at your own
risk. You are encouraged to do your own research before making any
investment decision in regards to the secu rity discussed herein. The
author has not been rewarded by any entity in connection with the
disbursement of these materials. You should assume that as of the date of
this report or letter, the author, possibly along with or through our
owners, affiliates, employees and/or consultants, (communally referred to
as the author) has a position in all company shares (and/or options of the
shares) covered herein that is consistent with the position set forth in
our report. In connection with PLPL, the author has taken a long position.
Following the disbursement of any report or letter, the author intends to
continue engaging in trnsactns in the security covered herein, and we may
be long, short, and/or neutral at any time hereafter regardless of our
initial position and we preserve the right to procure or trade all or part
of our position at any time without notice. This practice could end in our
trading securities at any time before, during, and/or after the
distribution of this report.
To stop receiving these
30 South Wacker Dr., 22nd Floor, Chicago, Ill.IL 60606 U.S.A.